Adaptive Biotechnologies Corp Annual Selling and Marketing Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Adaptive Biotechnologies Corp quarterly/annual Selling and Marketing Expense history and growth rate from 2017 to 2023.
  • Adaptive Biotechnologies Corp Selling and Marketing Expense for the quarter ending June 30, 2024 was $20.3M, a 14.9% decline year-over-year.
  • Adaptive Biotechnologies Corp Selling and Marketing Expense for the twelve months ending June 30, 2024 was $85M, a 6.98% decline year-over-year.
  • Adaptive Biotechnologies Corp annual Selling and Marketing Expense for 2023 was $88.6M, a 7.35% decline from 2022.
  • Adaptive Biotechnologies Corp annual Selling and Marketing Expense for 2022 was $95.6M, a 0.15% increase from 2021.
  • Adaptive Biotechnologies Corp annual Selling and Marketing Expense for 2021 was $95.5M, a 55.6% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $88.6M -$7.02M -7.35% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $95.6M +$138K +0.15% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $95.5M +$34.1M +55.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $61.4M +$22.9M +59.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-14
2019 $38.5M +$14M +57% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $24.5M +$7.72M +46.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $16.8M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.